Pendal Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Pendal Group’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,420	Closed	-$233K	–	547
2022 Q3	$233K	Buy	+3,420	New	+$189K	﹤0.01%	427
2020 Q3	–	Sell	-5,693	Closed	-$359K	–	515
2020 Q2	$359K	Buy	+5,693	New	+$390K	﹤0.01%	353

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pendal Group's GBT Position: Q4 2022 in Review

Pendal Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,420 shares — an estimated $233K sold.

Pendal Group first reported a position in GBT in Q2 2020 and held it in 2 quarters. The position peaked at $359K in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Pendal Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Pendal Group sold 3,420 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $233K.
Pendal Group first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 2 quarters.
Pendal Group's Global Blood Therapeutics, Inc. position peaked at $359K in Q2 2020.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.